TAM
ABBV icon

Titleist Asset Management’s AbbVie ABBV Stock Holding History

Titleist Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$716K Buy
2,738
+14
+0.5% +$3.59K 0.05% 240
2026
Q2 		$686K Sell
2,724
-1,457
-35% -$313K 0.05% 238
2026
Q1 		$909K Sell
4,181
-185
-4% -$41K 0.07% 184
2025
Q4 		$998K Buy
4,366
+918
+27% +$209K 0.08% 152
2025
Q3 		$798K Buy
3,448
+83
+2% +$16.9K 0.07% 158
2025
Q2 		$625K Buy
3,365
+1,635
+95% +$304K 0.06% 178
2025
Q1 		$362K Buy
1,730
+211
+14% +$41K 0.04% 221
2024
Q4 		$270K Buy
1,519
+302
+25% +$55.5K 0.03% 265
2024
Q3 		$240K Sell
1,217
-43
-3% -$8.03K 0.03% 250
2024
Q2 		$216K Buy
1,260
+113
+10% +$18.7K 0.03% 243
2024
Q1 		$209K Buy
+1,147
New +$198K 0.04% 240
2023
Q4 		– Sell
-4,469
Closed -$666K – 221
2023
Q3 		$666K Buy
4,469
+162
+4% +$23.8K 0.14% 126
2023
Q2 		$580K Buy
4,307
+845
+24% +$124K 0.11% 138
2023
Q1 		$552K Buy
+3,462
New +$529K 0.12% 130

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Titleist Asset Management's ABBV Position: Q3 2026 in Review

Titleist Asset Management increased its AbbVie (ABBV) stake by 0.51% in Q3 2026, buying an estimated $3.59K and bringing the position to 2,738 shares worth $716K. The position accounts for 0.05% of the portfolio, ranked #240.

Titleist Asset Management first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. The position peaked at $998K in Q4 2025. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Titleist Asset Management held 2,738 shares of AbbVie worth $716K as of Q3 2026.
  • Titleist Asset Management bought 14 AbbVie shares in Q3 2026, an estimated $3.59K.
  • AbbVie made up 0.05% of Titleist Asset Management's portfolio in Q3 2026, its #240 holding.
  • Titleist Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • Titleist Asset Management's AbbVie position peaked at $998K in Q4 2025.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Titleist Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.